News
-
-
-
PRESS RELEASE
Q2 and H1 2025 financial results: Delivery Hero accelerates growth and expands profitability, updates full-year guidance
Delivery Hero SE reports accelerated growth and enhanced profitability in Q2 and H1 2025 financial results, updating full-year guidance. Company demonstrates strong operational performance and robust financial position -
-
PRESS RELEASE
EDAG Engineering Group AG: Decline in revenues and EBIT due to ongoing market restraint in the first half of 2025, expansion of defence activities
EDAG Engineering Group AG reports decline in revenues and EBIT for the first half of 2025 due to market restraint, focusing on defence activities for growth -
-
-
-
PRESS RELEASE
Positive development across all major KPI: STRABAG on track for profitable growth
STRABAG SE announces positive first half 2025 results with output up by 7% to €8.9 billion, order backlog at €28.4 billion (+13%), and EBIT increased by 58% to €129.4 million. Expansion into Australia contributing to growth -
REGULATED PRESS RELEASE
Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial
Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, marking a significant milestone in developing therapies for muscle loss in aging individuals
